Companies: 10,795·Total market cap: $144.5T

Kadimastem Ltd

Kadimastem Ltd

KMSTFOTCHealthcare

$3.21

$-0.10(-3.02%)

Market Cap$9503988

P/E Ratio—

52W High$9.07082

52W Low$0.6404

Avg Volume40K

Open$3.30

Beta0.57

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Kadimastem Ltd（KMSTF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KMSTF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-14.12Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding4.2MShares outstanding history

Next EarningsTBAEarnings history

探索 Kadimastem Ltd 数据

分析师预测—

股息不分红

盈利EPS $-6.33-59.45%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$26.5M▼ 119.89% YoY

202220232024

FY 2024EPS$-6.33▼ 59.45% YoY

202220232024

TTM:Revenue: $0.00Net Income: -$62.1MEPS: $-14.12View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$3.21-3.02%$9.5M #2

American Hemp Ventures, Inc.

$0.98+0.00%$16.5M #3

Antisense Therapeutics Limited

$0.01-76.00%$19.6M #4

OKYO Pharma Limited

$0.01+0.00%$22.7M #5

Noxopharm Limited

$0.05+0.00%$14.8M #6

Organicell Regenerative Medicine, Inc.

$2.74-0.27%$20.0M

股票表现

1D+18.45%

1W+8.08%

1M+1.90%

3M-55.23%

YTD-64.61%

1Y-64.61%

5Y-63.02%

关于 Kadimastem Ltd

CEORonen Twito

IPO DateFeb 1, 2021

Employees11

CountryIL

Websitekadimastem.com

Kadimastem Ltd a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipel…

Biotechnology HealthcareOTCIL

关于股票概览与关键数据

Kadimastem Ltd（KMSTF）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 1, 2021 在 OTC 上市。截至最近交易日，KMSTF 股价为 $3.21，市值约为 $9.5M。过去12个月累计回报 -64.61%，年初至今回报 -64.61%。

2024 财年 Kadimastem Ltd 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Kadimastem Ltd（KMSTF）股价为 $3.21，在 OTC 上市，52周区间为 $0.64 – $9.07。

KMSTF 最新股价KMSTF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议